Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : UPCA - Uniprime Capital Acceptance, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Janice Shell who wrote (520)	8/13/1999 4:56:00 PM
From: Jeffrey S. Mitchell	Read Replies (3) \| Respond to of 640

New York, Aug. 13 (Bloomberg) -- Uniprime Capital Acceptance Inc. and an executive were charged with defrauding investors by falsely claiming that a subsidiary of the auto dealer had discovered a treatment for AIDS, authorities said. Uniprime and the president of a subsidiary, Alfred Flores, were sued by the U.S. Securities and Exchange Commission in a New York federal court. Flores was arrested yesterday on related criminal charges that he issued false press releases in which he claimed to have found an AIDS treatment, officials said. The AIDS- related announcement boosted Uniprime's stock. Flores, a resident of Las Vegas, has a criminal record, including a 1984 conviction for conspiracy to commit a financially motivated murder, the SEC's suit said. During the time Flores claimed he was doing medical research in Europe, Flores was instead in a Colorado prison for the murder conviction, federal prosecutors in New York said. Las Vegas-based Uniprime claimed, falsely, that Flores's subsidiary, New Technologies & Concepts Inc., had developed an intravenous treatment, called Plasma Plus, that reversed infections from the HIV virus in five patients treated in Madrid, the charges said. Uniprime shares fell 3/8 to 3/4 in recent trading. Aug/13/1999 15:34 For more stories from Bloomberg News, click here. (C) Copyright 1999 Bloomberg L.P. Any redistribution of Bloomberg content, including by framing or similar means, is expressly prohibited without the prior written consent of Bloomberg L.P. Any reference to the material must be properly attributed to Bloomberg News. The information herein was obtained from sources which Bloomberg L.P. and its suppliers believe reliable, but they do not guarantee its accuracy. Neither the information, nor any opinion expressed, constitutes a solicitation of the purchase or sale of any securities or commodities.(C) Copyright 1999 Bloomberg L.P. BLOOMBERG, Bloomberg News, Bloomberg Financial Markets, Bloomberg Television, Bloomberg News Radio are trademarks, tradenames and service marks of Bloomberg L.P. quote.bloomberg.com